Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques
about
Vaccines for gonorrhea: can we rise to the challenge?Optimal Use of Vaccines for Control of Influenza A Virus in SwineAdvanced vaccine candidates for Lassa feverCross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesThe use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.Pandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets.Memory B cells and CD8⁺ lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques.An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal miceComparison of influenza and SIV specific CD8 T cell responses in macaquesDesign of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particlesEfficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant.A mucosal adjuvant for the inactivated poliovirus vaccine.Alphavirus replicon vaccines.Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.Self-replicating alphavirus RNA vaccines.Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.Semliki Forest VirusExpression System
P2860
Q21131153-3CBC1686-D0B5-49FF-8F9E-DE35E63FDAF3Q26783503-7437AA1B-FA5B-4627-A51B-254C77730249Q26823627-CC266A6A-9F33-4691-810D-270282D04474Q27348520-D10C5723-31E0-4CC5-B98C-3E09661FBDE4Q30372479-2203C7ED-5403-4895-8461-36D1D40C7F14Q30374431-A8F82FDA-463F-40AE-AA0E-A45B184B70CAQ33957968-2E17758F-29CE-46DF-93CB-74D902986B81Q34059308-5498B632-23C2-40C5-B562-C6CE293013FCQ34189478-8E3D76F2-2D8F-4C77-A679-B9B677AFC71FQ35076889-9F2583E0-C01F-4B06-9D90-E33841635EDEQ36458651-1BA14422-AD3B-4DB9-8489-56D095CDBFB4Q37395334-557A495A-78D7-4FD3-A423-C0DB43517356Q37668140-8CB0ADC1-9415-41D6-8708-83BC05AC578DQ37995803-9738FF5B-C621-4080-A2A0-2C9B032F81FAQ38205757-6DFFF221-698B-490D-AC24-ABE4E7361C0BQ38255634-DD7013FF-8235-4522-A03F-8DE5D055D957Q38269845-B6E886E6-9466-424A-AD55-3E8C74AA797BQ51783750-B699C748-ED0E-4C9C-9AC9-F641203D6652Q56922178-BF08C928-61EC-446D-AE44-684887121069
P2860
Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@ast
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@en
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@nl
type
label
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@ast
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@en
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@nl
prefLabel
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@ast
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@en
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@nl
P2093
P2860
P1433
P1476
Alphavirus replicon-based adju ...... f Fluzone ® in rhesus macaques
@en
P2093
Christopher J Miller
Linda Fritts
Mario Barro
Michael B McChesney
Robert E Johnston
Shannon R Matzinger
Timothy D Carroll
P2860
P304
P356
10.1016/J.VACCINE.2010.11.024
P407
P577
2011-01-29T00:00:00Z